|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 21 | 2022 | PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment | Thouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P.; De Greve, J. | Journal Contribution | A1 |
| 62 | 2022 | The perspective of patients on the use of telemedicine in cardiovascular care | Knaepen, L.; Essarti, H.; Vervoort, Y.; Driesen , K.; MEBIS, Jeroen; Vandenberk, F.; Vanoppen, A.; DENDALE, Paul; DESTEGHE, Lien; HEIDBUCHEL, Hein | Journal Contribution | M |
| 63 | 2022 | Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, Jeroen | Journal Contribution | M |
| 64 | 2022 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, Jeroen | Journal Contribution | A1 |
| 65 | 2022 | Photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy (NEUROLASER trial) | LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Hermans, S.; MEBIS, Jeroen | Journal Contribution | M |
| 66 | 2022 | A long‐term follow‐up of early breast cancer patients treated with photobiomodulation during conventional fractionation radiotherapy in the prevention of acute radiation dermatitis | ROBIJNS, Jolien; LODEWIJCKX, Joy; CLAES, Marithe; Lenaerts, Melissa; Van Bever, Leen; Claes, Stefan; Pannekoeke, Luc; Verboven, Katleen; Noé, Leen; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 67 | 2021 | A digital automated health monitoring system for oncology patients during the COVID-19 pandemic: Practical issues and lessons for the future | ROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, Jeroen | Journal Contribution | A1 |
| 68 | 2021 | A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis | Brufsky, A.; Kim, S. B.; Zvirbule, Z.; Eniu, A.; MEBIS, Jeroen; Sohn, J. H.; Wongchenko, M.; Chohan, S.; Amin, R.; Yan, Y.; McNally, V; Miles, D.; Loi, S. | Journal Contribution | A1 |
| 69 | 2021 | Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial) | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 70 | 2021 | Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study | Joris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J. | Journal Contribution | M |
| 71 | 2021 | Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et al | ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, Jeroen | Journal Contribution | A1 |
| 72 | 2021 | Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)" | ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, Stefan | Journal Contribution | A1 |
| 73 | 2021 | The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: Preliminary results of a randomized, placebo-controlled trial | LODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, S; MEBIS, Jeroen | Journal Contribution | M |
| 74 | 2021 | Photobiomodulation therapy can prevent the development of severe acute radiodermatitis in head and neck cancer patients: A multicentric, randomized controlled trial | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 75 | 2021 | The safe use of photobiomodulation therapy in an oncologic setting | ROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, Jeroen | Journal Contribution | M |
| 76 | 2020 | A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical Studies | ROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 77 | 2020 | Preliminary results of a multicentric, placebo-controlled clinical trial | ROBIJNS, Jolien; LODEWIJCKX, Joy; Puts , Sofie; Claes, Stefan; Van Bever, Leen; Busse, Lore; Colson , Dora; Kaminski, Iris; Broux, Victoria; MAES, Annelies; BULENS, Paul; Noe, Leen; Brosens, Marc; Govers, Mieke; Timmermans, An; MEBIS, Jeroen | Journal Contribution | M |
| 78 | 2020 | Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An Overview | LODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, Jeroen | Journal Contribution | A1 |
| 79 | 2020 | Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results | Catala, Gaetan; MEBIS, Jeroen; Jerusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van Den Broeck, Anke; Duhoux, Francois P; Machiels, Jean-Pascal | Journal Contribution | A1 |
| 80 | 2019 | Quality of life, fatigue, and subjective cognitive functioning immediately and 6 months after adjuvant chemotherapy in breast cancer patients | MEBIS, Jeroen; Censabella, S; Engels, Sofie; Van Marsenille, C.; ORYE, Guy; MARQUETTE, Sophie; Vansteelant, L.; Luyten, D.; MAES, Annelies; Noé, L; BULENS, Paul | Journal Contribution | M |
Loading...
5
0
5
0
false